|B-09 Marc Gastonguay|
Proposal for a Web-Based Open Pharmacometrics Curriculum
|C-06 Scott Marshall|
Good Practices in Model Informed Drug Discovery and Development (MID3): Practice, Application, Documentation and Reporting
|C-07 Terry Shepard|
How European Regulators are Facilitating the Use of Modelling and Simulation: MSWG History, Activity and Future
|C-08 Efthymios Manolis|
EMA qualification of novel methodologies: are we ready for M&S ?
|C-12 Vikram Sinha|
The Role of Model Based Drug Development – Is it time to repaint the canvas?
|D-06 Sharon Hori|
Modeling cancer blood biomarker dynamics in relation to tumor growth